Katleen Vereecken

Katleen Vereecken is a virology researcher at the Institute of Tropical Medicine Antwerp (ITG) in Belgium with an extensive publication record spanning from 1995 to 2023. She has contributed to 33 research outputs with primary focus on viral pathogens including HIV-1, Chikungunya virus, and SARS-CoV-2. Her work is consistently published in reputable scientific journals with recent contributions appearing in Antibiotics-Basel, Viruses, Vaccines, and Frontiers in Microbiology.

Dr. Vereecken's research spans multiple critical areas of virology, with particular expertise in viral pathogenesis and host-pathogen interactions. Her fingerprint analysis reveals strong concentrations in HIV-1 research (100%), Chikungunya virus studies (90%), Reverse Transcriptase Inhibitors (57%), and Dapivirine research (47%). She also investigates non-ribosomal peptide synthases, polyketide synthases, and SARS virus mechanisms, demonstrating a broad yet specialized approach to viral research.

Her recent publications demonstrate a strategic focus on emerging viral threats, with significant contributions to understanding SARS-CoV-2 variants and vaccine efficacy against Omicron, alongside continued investigation of alphaviruses like Chikungunya. Her work integrates molecular virology, cell biology, and genomic approaches to address critical questions about viral replication, adaptation, and host cell entry mechanisms. Notably, her 2022 paper on Chikungunya virus adaptation mechanisms has received significant attention with 24 Mendeley readers.

While no specific awards are mentioned in the available documentation, her research impact is evident through citation metrics and reader engagement across multiple platforms including X (formerly Twitter) and academic networks like Mendeley. Her work on the Omicron variant has garnered policy citations, indicating real-world impact on public health decision-making.

Dr. Vereecken maintains active collaborations with key researchers at ITG, particularly with K.K. Ariën, L. Heyndrickx, and K. Bartholomeeusen, suggesting she is embedded within a productive research team focused on viral pathogenesis and antiviral strategies. Her laboratory work appears to focus on molecular mechanisms of viral entry and replication, with particular emphasis on Chikungunya virus and related alphaviruses.